scientific programme - International Society of Blood Transfusion

More documents

Recommendations

Info

SCIENTIFIC PROGRAMME P R E - C O N G R E S S S Y M P O S I U M SATURDAY, JULY 2, 2005 17.00-20.00 Blood Transfusion update in the Middle East - Faten Moftah E D U C A T I O N D A Y 6 SUNDAY, JULY 3, 2005 09.00-10.30 SESSIONS 1: QUALITY OF EVIDENCE IN TRANSFUSION MEDICINE ñ Assessing clinical evidence - D.B.L McClelland, UK ñ Are transfusion guidelines evidence-based - J.P. AuBuchon, USA ñ Clinical trials; End points; Systematic reviews - E. Vamvakas, Canada SESSION 2: HAEMOPOIETIC STEM CELLS ñ Haematopoiesis – Stem cell mobilization – Th. Papayannopoulou, USA ñ Stem cell transplantation; cord blood vs Peripheral blood stem-cells – E. Gluckman, France ñ Developmental plasticity of the bone-marrow derived cells – G. Vassilopoulos, USA 10.30-11.00 Coffee break 11.00-12.30 SESSIONS 3: SAFE BLOOD ADMINISTRATION ñ Risk management in transfusion medicine – L. Loukopoulou, Greece ñ How effective are initiatives for safer blood transfusion; procedures; devices – Jan Jorgensen, Denmark ñ Strategies to reduce transfusion associated septic risk – R. Eglin, UK SESSION 4: TRANSFUSION PRACTICE ñ Young vs Old RBC units; Rheology; Oxygen Transport - D. Spahn, Switzerland ñ How close are we to using universal RBCs – M.L. Olsson, Sweden ñ Blood volume replacement – FFP vs Colloids vs Crystalloids, – H.J. Dieterich, Germany 12.30-13.30 Lunch break 13.30-15.00 SESSION 5: HAEMOSTASIS ñ Physiological mechanisms; clinical and laboratory assessment – S. Machin, UK ñ The role of lab and point of care diagnostics in predicting and managing perioperative bleeding – G. Despotis, USA ñ Diagnosis and management of acute and chromic DIC – M. Levy, the Netherlands SESSION 6: IMMUNOHAEMATOLOGY ñ Molecular technics in blood-grouping – David Anstee, UK ñ Dealing with immunological refractoriness to platelet transfusions – M. Contreras, UK ñ The HLA system – A. Stavropoulou, Greece SESSION 7: WHEN ARE BLOOD COMPONENTS CLINICALLY EFFECTIVE; WHAT DO WE REALLY KNOW ñ Platelets – P. Rebulla, Italy ñ FFP – S. Stanworth, UK ñ Granulocytes – S. Leitman, USA 15.00-15.30 Tea Break 15.30-17.00 SATELLITE SYMPOSIUM (to be announced) 18.30-20.00 OPENING CEREMONY at the International Conference Centre, Megaron, Athens Concert Hall 20.00 WELCOME RECEPTION in the Exhibition Area
MONDAY, JULY 4, 2005 09.00-10.30 PLENARY LECTURES Impact of the EU directive Chair: F. Delaney, European Commission, Luxembourg ñ Is the landscape for blood collection and distribution changing in Europe – J. Koistinen, Finland ñ Adopting the EU directive: – In France – Ph. Rouger, – In Sweden – O. Ackerblom – In Poland – M. Letowska 10.30-11.00 Coffee break 11.00-12.30 PARALLEL SESSIONS Apheresis ñ Multicomponent donation – O. Flesland, Norway ñ Hemapheresis guidelines – G. Andreu, France ñ Therapeutic apheresis – to be announced Fresh Frozen Plasma ñ Alternative methods for prevention of infection transmission (pathogen inactivation etc.); cost-benefit considerations – T. Hervig, Norway ñ Clinical use of plasma in Europe – C. Velati, Italy Immunologic reactions to transfusion ñ TRALI – P. Kopko, USA (tbc) ñ TA-GvHD – L. Corash, USA (tbc) 12.30-14.00 Lunch break, visit to the exhibition and posters 12.30-14.00 SATELLITE SYMPOSIA, organised by Baxter and Macopharma 14.00-15.30 PARALLEL SESSIONS Bleeding – Thrombosis ñ Bleeding due to anticoagulants or new antiplatelet agents – M. Samama, France ñ New anticoagulants for the treatment of thromboembolism – J.I. Weitz, Canada (tbc) Transplantation ñ Peripheral blood stem cells – new applications – W. Fibbe, the Netherlands (tbc) ñ The role of cord blood in auto and allo-transplantation – P. Rubinstein, USA Hospital transfusion committees ñ What is the impact of audits on transfusion practices – J. AuBuchon, USA ñ Informed consent – A. Maniatis, Greece ñ Reporting of transfusion errors: ethics and risks – P. Strengers, the Netherlands 15.30-17.00 PARALLEL SESSIONS Transfusion transmitted diseases ñ Evolution of viruses – to be announced ñ Emerging pathogens – Ch. Prowse, UK ñ New methods and current trends in donor testing – J. Barbara, UK Immunohematology ñ Partial D and its clinical significance – C. Gassner, Vienna, Austria ñ Immunofluorescence cytometry for immunohematology testing – J. Roback, USA ñ Detection of fetal cells in maternal blood – E. van der Schoot, the Netherlands Developing transfusion strategies ñ In surgery – P. Van der Linden, Belgium ñ In pediatrics – N. van Leeuwen, the Netherlands ñ Transfusion triggers and the influence of cell storage – S. McLellan, UK 17.00-19.30 GENERAL EXCURSION For more information see page 16 SCIENTIFIC PROGRAMME 7
Page 2 and 3: TABLE OF CONTENTS 2 WORDS OF WELCOM
Page 4 and 5: ORGANISATION - COMMITTEES 4 ORGANIS
Page 8 and 9: SCIENTIFIC PROGRAMME 8 TUESDAY, JUL
Page 10 and 11: ABSTRACT SUBMISSION Deadline date f
Page 12 and 13: REGISTRATION INFORMATION How to reg
Page 14 and 15: GENERAL INFORMATION 14 Registration
Page 16 and 17: SOCIAL PROGRAMME Opening Ceremony a
Page 18 and 19: HOTEL ACCOMMODATION 18 Confirmation

scientific programme - International Society of Blood Transfusion

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?